Catalio Capital Seeks $500 Million for AI-Healthcare Startups, Bloomberg Reports

3-line summary

• Catalio Capital is seeking $500 million for its second AI-healthcare-startup fund, named Nexus V, moved up from a previously planned 2027 launch, according to an investor letter cited by Bloomberg. Five existing portfolio companies will carry over into the new fund, including Doctronic (AI personalized healthcare) and Basecamp Research (AI-designed therapeutics).
• Catalio's prior fund closed in July 2025 at over $400 million, with about 40% of its portfolio AI-related. The firm has sold three portfolio companies this year for a combined deal value exceeding $8 billion, and has taken seven companies public, including this week's $150 million Iambic Therapeutics IPO and June's $745 million Parabilis Medicines IPO.
• KKR took a minority stake in Catalio in 2023, and KKR co-founder Henry Kravis chairs Catalio's board.

This summary is our own processing of the source article; see the source link below for full context.